The company raised its full-year adjusted earnings forecast to $2.30-$2.35 per share from $2.20-$2.30 per share. Analysts on average were expecting $2.28 per share, according to Thomson Reuters I/B/E/S. The company said it expected net yields, a measure of ticket sales and money spent onboard, to rise about 3 percent in 2013.

-----

This is the effect of light, choppy and directionless trade before the holidays," said Mark Waggoner, president of Excel Futures Inc in Oregon. Crude trading volumes on the New York Mercantile Exchange remained thin, with many players out due to the holidays. "The market seemed exhausted. It's coming down a bit after all the upward momentum in the past few days.

-----

* Media: Can browse websites to stream movies, music and TV shows as well as applications on the Android market * On sale: five-inch model in stores now but Dell has said it has a new tablet with a larger screen in the works. (Reporting by Liana Baker; Additional reporting by  Ritsuko Ando ; Editing by Leslie Adler)

-----

A consortium of banks provided commitments for a total of $22.5 billion in debt. * Impact - The deal is expected to add to Pfizer's earnings in the second full year after closing and result in cost savings of $4 billion by the third year. COMBINED COMPANY * CEO -- Jeff Kindler * Employees -- 129,500.

-----

The concern was that "shortly after these types of meetings, trading would take place on the basis of such information," Goldman said. "This seems a lot different from that." The new potential action raises questions about whether the rule was designed to address disclosures like the one made by Hastings. "There's a huge divide between CEOs living in the real world and the financial industry, which lives behind regulatory walls.
